We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Critical Outcome Technologies and Delmar Chemicals Sign Collaboration Agreement

News   Sep 12, 2012

 
Critical Outcome Technologies and Delmar Chemicals Sign Collaboration Agreement
 
 
 

RELATED ARTICLES

Open Science Drug Discovery Approach Targets Neurodegenerative Disease

News

Parkinson’s disease and Amyotrophic Lateral Sclerosis, or ALS, are the newest frontiers for open science drug discovery, a global movement led by University of Toronto researchers that puts knowledge sharing and medication affordability ahead of patents and profits.

READ MORE

100,000-person Study Investigates Association Between Antiepileptic Drugs and Dementia

News

A study has investigated the hypothetical association between antiepilipetic drug use and dementia risk in 101,150 individuals receiving treatment from more than 1,400 physicians in Germany.

READ MORE

A Better Understanding of How the Body Regulates Blood Clots

News

Scientists have discovered new ways in which the body regulates blood clots, in a discovery which could one day lead to the development of better treatments that could help prevent and treat conditions including heart diseases, stroke and vascular dementia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE